Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial (112372)
ARTG ID 112372
ARTG Name
TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial
Product name
TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Natalizumab
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information